Ratings by Jones Trading (Boris Peaker)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/29/2026 | Enliven Therapeutics | ELVN | Maintain | Buy (N/A) |
|
Details | ||
| 6/15/2026 | Elicio Therapeutics | ELTX | Downgrade | Hold (Buy) |
14.85 (3.19) |
-78.52% | Details | |
| 5/14/2026 | Adlai Nortye Ltd. | ANL | New Coverage | Buy (N/A) |
13.94 (13.28) |
-4.73% | Details | |
| 5/6/2026 | OnKure Therapeutics Inc. | OKUR | Downgrade | Hold (Buy) |
4.52 (4.14) |
-8.41% | Details | |
| 4/28/2026 | Janux Therapeutics | JANX | Maintain | Buy (N/A) |
|
Details | ||
| 4/6/2026 | Whitehawk Therapeutics | WHWK | New Coverage | Buy (N/A) |
3.51 (4.76) |
35.61% | Details | |
| 4/6/2026 | Protara Therapeutics | TARA | New Coverage | Buy (N/A) |
5.11 (4.12) |
-19.37% | Details | |
| 4/6/2026 | Prime Medicine | PRME | New Coverage | Buy (N/A) |
3.32 (3.08) |
-7.23% | Details | |
| 4/6/2026 | ORIC Pharmaceuticals | ORIC | New Coverage | Buy (N/A) |
8.89 (13.50) |
51.86% | Details | |
| 4/6/2026 | OnKure Therapeutics Inc. | OKUR | New Coverage | Buy (N/A) |
4.29 (4.52) |
5.36% | Details | |
| 4/6/2026 | Oncolytics Biotech | ONCY | New Coverage | Hold (N/A) |
0.96 (0.80) |
-16.67% | Details | |
| 4/6/2026 | Nuvation Bio Inc | NUVB | New Coverage | Buy (N/A) |
4.41 (6.60) |
49.66% | Details | |
| 4/6/2026 | Monopar Therapeutics | MNPR | New Coverage | Buy (N/A) |
55.13 (119.21) |
116.23% | Details | |
| 4/6/2026 | Janux Therapeutics | JANX | New Coverage | Buy (N/A) |
14.84 (15.85) |
6.81% | Details | |
| 4/6/2026 | IN8bio Inc. | INAB | New Coverage | Buy (N/A) |
1.44 (0.98) |
-31.94% | Details | |
| 4/6/2026 | Enliven Therapeutics | ELVN | New Coverage | Buy (N/A) |
38.83 (60.46) |
55.7% | Details | |
| 4/6/2026 | Elicio Therapeutics | ELTX | New Coverage | Buy (N/A) |
10.65 (14.85) |
39.44% | Details | |
| 4/6/2026 | Editas Medicine | EDIT | New Coverage | Buy (N/A) |
2.67 (2.88) |
7.87% | Details | |
| 4/6/2026 | Day One Biopharmaceuticals | DAWN | New Coverage | Hold (N/A) |
21.45 (21.53) |
0.37% | Details | |
| 4/6/2026 | Curis | CRIS | New Coverage | Buy (N/A) |
0.55 (4.02) |
630.91% | Details | |
| 4/6/2026 | Cullinan Oncology Inc. | CGEM | New Coverage | Buy (N/A) |
14.43 (17.73) |
22.87% | Details | |
| 4/6/2026 | Context Therapeutics | CNTX | New Coverage | Buy (N/A) |
2.72 (0.48) |
-82.35% | Details | |
| 4/6/2026 | CG Oncology | CGON | New Coverage | Buy (N/A) |
67.48 (75.10) |
11.29% | Details | |
| 4/6/2026 | CervoMed | CRVO | New Coverage | Buy (N/A) |
4.14 (2.87) |
-30.68% | Details | |
| 4/6/2026 | Bolt Biotherapeutics, Inc. | BOLT | New Coverage | Hold (N/A) |
4.29 (4.05) |
-5.59% | Details | |
| 4/6/2026 | Bicara Therapeutics Inc | BCAX | New Coverage | Buy (N/A) |
21.47 (28.06) |
30.69% | Details | |
| 4/6/2026 | Beam Therapeutics Inc | BEAM | New Coverage | Buy (N/A) |
24.66 (27.48) |
11.44% | Details | |
| 4/6/2026 | aTyr Pharma | ATYR | New Coverage | Hold (N/A) |
0.85 (0.51) |
-40% | Details | |
| 4/6/2026 | ArriVent BioPharma | AVBP | New Coverage | Buy (N/A) |
24.89 (30.84) |
23.91% | Details | |
| 4/6/2026 | Adicet Bio Inc. | ACET | New Coverage | Buy (N/A) |
6.99 (7.98) |
14.16% | Details |
